Product logins

Find logins to all Clarivate products below.


Epidemiology of Pediatric Ischemic Stroke prepared exclusively for AbbVie.

Epidemiology of Pediatric Ischemic Stroke in EU5.

Table of Contents:

 

1. Stroke Literature Review Data – EU5

2. Stroke Literature Review Data – Non-EU5

3. Stroke Hospital Discharge Review Data

4. Stroke Case Estimates

5. Methods

6. Key Sources

7. PRISMA Diagram

8. Bibliography

 

Related Market Assessment Reports

Report
Squamous Cell Carcinoma of the Head and Neck – Landscape & Forecast – Disease Landscape & Forecast (G7)
Squamous cell carcinoma of the head and neck (SCCHN) is the seventh most commonly diagnosed cancer. It encompasses a spectrum of heterogeneous tumors originating at multiple sites in the head and…
Report
Ischemic Stroke – Landscape & Forecast – Disease Landscape & Forecast (G7)
Acute ischemic stroke (AIS) affects millions of individuals across G7 countries, according to Clarivate Epidemiology’s tracked lifetime and 12-month prevalent cohorts. As a time-critical…
Report
Hemophilia A – Current Treatment – Current Treatment: Physician Insights – Hemophilia A with Inhibitors (US)
Development of neutralizing antibodies against factor VIII replacement is the most significant clinical complication in hemophilia A, necessitating specialized and often high-cost management…
Report
Major Depressive Disorder (DSM-V) – Access & Reimbursement – Access & Reimbursement – Major Depressive Disorder (US)
Numerous drugs from multiple drug classes are used as monotherapies and/or adjunctive therapies to treat major depressive disorder (MDD). Early-line treatment is dominated by generically available…
Report
Malignant Melanoma – Unmet Need – Unmet Need – BRAF Wild-Type, Unresectable or Metastatic Malignant Melanoma (US/EU)
Treatment for BRAF wild-type unresectable or metastatic melanoma has been largely shaped by the successive approvals of immune checkpoint inhibitors. Anti-PD-1 agents such as Keytruda (Merck & Co…